While Germany / Europe is on an upwards trajectory, it is wise to consider the time right for relaxation of containment, or if it is the time to reconsider a low incidence strategy.

Which of the two brings back citizens' freedoms rather?

The authors of the strategy papers (nocovid-europe.eu/) pursued from the beginning a dual aim: keep incidence down with decentralised and aggressive containment, while dropping restrictions in "green zones" of low incidence.


Currently, it is purported that the Australian example demonstrates the failure of NoCovid.

Does it?

The NoCovid papers suggest a mixture of non-pharmaceutical interventions to react swiftly and locally to coronavirus outbreaks, which may escalate to multiple locations incrementally, but also accompany these measures with , a pharmaceutical intervention.


The Delta variant shows the limits of effectiveness for containment, but to claim NoCovid had failed would imply that the better strategy would be either (a) delocalised lockdown, or (b) dropping containment entirely (maybe except vaccination, as it seems to be a belief in Germany).



Not to forget, high incidence means replication implies mutation, and the emergence of more aggresive variants may not be a necessity but no impossibility either (chemistryworld.com/news/race-t).


So what is the core of the NoCovid strategy?

(1) keep testing
(2) only allow infections go unchallenged when the infection chains can be traced and contained
(2) where this applies, reopen as a "green zone"

It's a strategy that can be applied everywhere, and accelerates responses to rising incidence. A potential emergence of new variants can be spotted early through testing, enabling also containment of variants that may evade immune responses (again: chemistryworld.com/news/race-t)


So we can level up our guard while maximising freedom rights AND keep overview of the incidence, or lower the guard and hope for the best without watching.

It's our choice.


Sign in to participate in the conversation

Fediscience is the social network for scientists.